首页> 外文OA文献 >Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

【2h】

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

机译：肌肉肿瘤治疗阵发性夜间血红蛋白和非典型溶血性尿毒综合征的抗生态C5疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Edwin K.S. Wong; David Kavanagh;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anticomplement 05 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome [J] . Wong Edwin K. S., Kavanagh David Translational research: the journal of laboratory and clinical medicine . 2015,第2期

机译：Eculizumab抗补体疗法05治疗阵发性夜间血红蛋白尿和非典型溶血性尿毒症综合征
2. MODELING AND SIMULATIONS OF ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) PATIENTS. [J] . Lathia C., Kassir N., Mouksassi M. S., Clinical Pharmacology and Therapeutics . 2014,第Suppla1期

机译：阵发性夜间血红蛋白尿（PNH）和非典型溶血性尿毒症综合征（AHUS）患者的依库丽单抗建模和模拟。
3. MODELING AND SIMULATIONS OF ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) PATIENTS [J] . Lathia C., Kassir N., Mouksassi M. S., Clinical Pharmacology and Therapeutics . 2014,第Suppla1期

机译：阵发性夜间血红蛋白尿（PNH）和非典型溶血性尿毒症综合征（AHUS）患者的依库珠单抗建模与模拟
4. A Patient with Paroxysmal Nocturnal Hemoglobinuria in whom G-CSF Administration was Remarkably Effective against Recurrent Gastrointestinal Infections and Hemolytic Episodes Caused by Cellular Immunodeficiency [C] . T. Matsunaga, A. Fujimi, N. Takemoto, International Symposium on PNH and Related Disorders . 2003

机译：患有阵发性夜间血红蛋白尿的患者，G-CSF给药对由细胞免疫缺陷引起的复发性胃肠道感染和溶血发作显着有效
5. Bacterial factors contributing to the pathogenesis of the hemolytic uremic syndrome. [D] . Edwards, Kelly Katherine. 2002

机译：导致溶血性尿毒症综合征发病机理的细菌因素。
6. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome [O] . Xuan Yuan, Eleni Gavriilaki, Jane A. Thanassi, 2017

机译：小分子D因子抑制剂选择性地阻断阵发性夜间血红蛋白尿和非典型溶血性尿毒症综合征的补体替代途径
7. Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience [O] . Morag Griffin, Austin Kulasekararaj, Sheyans Gandhi, 2018

机译：具有免疫抑制治疗和生态抑制作用和生态抑血症/阵发性夜间血红蛋白尿素综合征的同步处理：英国经验

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

著录项

引文网络

相似文献

相关主题

期刊订阅